Stock Scorer

LifeStance Health Group, Inc. (LFST)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 150M 300M 450M Q3 '21: 173.8M Q4 '21: 190M Q1 '22: 203.1M Q2 '22: 209.5M Q3 '22: 217.6M Q4 '22: 229.4M Q1 '23: 252.6M Q2 '23: 259.6M Q3 '23: 262.9M Q4 '23: 280.6M Q1 '24: 300.4M Q2 '24: 312.3M Q3 '24: 312.7M Q4 '24: 325.5M Q1 '25: 333M Q2 '25: 345.3M Q3 '25: 363.8M Q4 '25: 382.2M Q1 '26: 403.5M Q2 '26: 435.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '21: -124.7M Q4 '21: -113.8M Q1 '22: -64.9M Q2 '22: -60.5M Q3 '22: -38.8M Q4 '22: -46M Q1 '23: -34.1M Q2 '23: -48.4M Q3 '23: -74.4M Q4 '23: -32.3M Q1 '24: -16.8M Q2 '24: -15.9M Q3 '24: 47K Q4 '24: 1.1M Q1 '25: 1.6M Q2 '25: -3M Q3 '25: 7.4M Q4 '25: 18.1M Q1 '26: 22.3M Q2 '26: 30.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '21: -120.5M Q4 '21: -108M Q1 '22: -62.3M Q2 '22: -68.7M Q3 '22: -37.9M Q4 '22: -46.7M Q1 '23: -34.2M Q2 '23: -45.5M Q3 '23: -61.6M Q4 '23: -45M Q1 '24: -21.1M Q2 '24: -23.3M Q3 '24: 709K Q4 '24: -7.1M Q1 '25: 709K Q2 '25: -3.8M Q3 '25: 1.1M Q4 '25: 11.7M Q1 '26: 14.2M Q2 '26: 23.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-35M 0 35M 70M 105M Q3 '21: -14.2M Q4 '21: 30.6M Q1 '22: 3.3M Q2 '22: 7.8M Q3 '22: 5.7M Q4 '22: 35.9M Q1 '23: -7.9M Q2 '23: -434K Q3 '23: -25.4M Q4 '23: 16.8M Q1 '24: -21.8M Q2 '24: 44.1M Q3 '24: 22.7M Q4 '24: 62.3M Q1 '25: -3.1M Q2 '25: 64.4M Q3 '25: 27.3M Q4 '25: 57.6M Q1 '26: 33.1M Q2 '26: 99.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-60M -30M 0 30M 60M 90M Q3 '21: -38.2M Q4 '21: -8M Q1 '22: -24.6M Q2 '22: -18M Q3 '22: -9.4M Q4 '22: 25.5M Q1 '23: -15.6M Q2 '23: -12M Q3 '23: -35.2M Q4 '23: 5.4M Q1 '24: -26.9M Q2 '24: 39M Q3 '24: 17.7M Q4 '24: 56M Q1 '25: -10.3M Q2 '25: 56.6M Q3 '25: 17M Q4 '25: 46.6M Q1 '26: 22.3M Q2 '26: 87.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q2 '21: 313.5K Q3 '21: 343.4K Q1 '22: 350.8K Q2 '22: 353.7K Q3 '22: 357.5K Q1 '23: 360.9M Q2 '23: 363.2M Q3 '23: 372.5M Q1 '24: 376.3M Q2 '24: 379.4M Q3 '24: 380.4M Q1 '25: 390.7M Q2 '25: 386.7M Q3 '25: 388.9M Q1 '26: 395.1M Q2 '26: 387.3M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

Not drawn for LFST: Gross Profit, Cost of Revenue, EPS. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.